Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
29 Dec 2022
Historique:
entrez: 29 12 2022
pubmed: 30 12 2022
medline: 31 12 2022
Statut: epublish

Résumé

The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible treatment of childhood pneumonia for the improvement of current pneumonia case management guidelines. Using data from a published systematic review and expert knowledge, we identified studies meeting our eligibility criteria and invited investigators to share individual-level patient data. We collected data on demographic information, general medical history, and current illness episode, including history, clinical presentation, chest radiograph findings when available, treatment, and outcome. Data were gathered separately from hospital-based and community-based cases. We performed a narrative synthesis to describe the final data set. Forty-one separate data sets were included in the Pneumonia Research Partnership to Assess WHO Recommendations (PREPARE) database, 26 of which were hospital-based and 15 were community-based. The PREPARE database includes 285 839 children with pneumonia (244 323 in the hospital and 41 516 in the community), with detailed descriptions of clinical presentation, clinical progression, and outcome. Of 9185 pneumonia-related deaths, 6836 (74%) occurred in children <1 year of age and 1317 (14%) in children aged 1-2 years. Of the 285 839 episodes, 280 998 occurred in children 0-59 months old, of which 129 584 (46%) were 2-11 months of age and 152 730 (54%) were males. This data set could identify an improved specific, sensitive set of criteria for diagnosing clinical pneumonia and help identify sick children in need of referral to a higher level of care or a change of therapy. Field studies could be designed based on insights from PREPARE analyses to validate a potential revised pneumonia algorithm. The PREPARE methodology can also act as a model for disease database assembly.

Sections du résumé

Background UNASSIGNED
The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. We aimed to collate an individual patient-level data set from large, high-quality pre-existing studies on pneumonia in children to identify a set of signs and symptoms with greater validity in the diagnosis, prognosis, and possible treatment of childhood pneumonia for the improvement of current pneumonia case management guidelines.
Methods UNASSIGNED
Using data from a published systematic review and expert knowledge, we identified studies meeting our eligibility criteria and invited investigators to share individual-level patient data. We collected data on demographic information, general medical history, and current illness episode, including history, clinical presentation, chest radiograph findings when available, treatment, and outcome. Data were gathered separately from hospital-based and community-based cases. We performed a narrative synthesis to describe the final data set.
Results UNASSIGNED
Forty-one separate data sets were included in the Pneumonia Research Partnership to Assess WHO Recommendations (PREPARE) database, 26 of which were hospital-based and 15 were community-based. The PREPARE database includes 285 839 children with pneumonia (244 323 in the hospital and 41 516 in the community), with detailed descriptions of clinical presentation, clinical progression, and outcome. Of 9185 pneumonia-related deaths, 6836 (74%) occurred in children <1 year of age and 1317 (14%) in children aged 1-2 years. Of the 285 839 episodes, 280 998 occurred in children 0-59 months old, of which 129 584 (46%) were 2-11 months of age and 152 730 (54%) were males.
Conclusions UNASSIGNED
This data set could identify an improved specific, sensitive set of criteria for diagnosing clinical pneumonia and help identify sick children in need of referral to a higher level of care or a change of therapy. Field studies could be designed based on insights from PREPARE analyses to validate a potential revised pneumonia algorithm. The PREPARE methodology can also act as a model for disease database assembly.

Identifiants

pubmed: 36579417
doi: 10.7189/jogh.12.04075
pmc: PMC9798037
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04075

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2022 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare the following activities and relationships: YBN is staff member of the World Health Organization.

Références

Pediatr Pulmonol. 2020 Jun;55 Suppl 1:S37-S50
pubmed: 32074408
J Glob Health. 2021 Oct 09;11:04062
pubmed: 34737862
Lancet. 2013 Apr 20;381(9875):1405-1416
pubmed: 23582727
PLoS One. 2018 Feb 22;13(2):e0193557
pubmed: 29470524
Lancet. 2022 May 28;399(10340):2047-2064
pubmed: 35598608
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
Lancet Respir Med. 2019 Dec;7(12):1068-1083
pubmed: 31591066
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Lancet. 2018 Jul 14;392(10142):145-159
pubmed: 30025808
Acute Med. 2019;18(3):141-143
pubmed: 31536050
Acta Trop. 2004 Apr;90(2):211-4
pubmed: 15177148
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Arch Dis Child. 2015 Feb;100 Suppl 1:S23-8
pubmed: 25613963
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
PLoS Med. 2020 Oct 23;17(10):e1003300
pubmed: 33095763
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Arch Dis Child. 1993 Apr;68(4):492-5
pubmed: 8503674
PLoS One. 2010 Aug 06;5(8):e11989
pubmed: 20700510
JAMA. 2017 Aug 01;318(5):462-471
pubmed: 28763554
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32792409
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
J Emerg Med. 2013 Nov;45(5):752-60
pubmed: 23937809
PLoS One. 2015 Sep 15;10(9):e0136166
pubmed: 26372640
BMJ Glob Health. 2022 Apr;7(4):
pubmed: 35428680
Lancet Infect Dis. 2015 Apr;15(4):439-50
pubmed: 25769269
Nature. 2015 Dec 3;528(7580):S53-9
pubmed: 26633766
PLoS One. 2019 Jun 20;14(6):e0214583
pubmed: 31220085
PLoS One. 2016 Jan 15;11(1):e0147560
pubmed: 26771879
Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):662-5
pubmed: 8296367

Auteurs

Helena Martin (H)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.

Jennifer Falconer (J)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.

Emmanuel Addo-Yobo (E)

Kwame Nkrumah University of Science and Technology/Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Satinder Aneja (S)

School of Medical Sciences and Research, Sharda University, Greater Noida, India.

Luis Martinez Arroyo (LM)

PNUD/National University, Montevideo, Uruguay.

Rai Asghar (R)

Rawalpindi Medical College, Rawalpindi, Pakistan.

Shally Awasthi (S)

King George's Medical University, Department of Pediatrics, Lucknow, India.

Salem Banajeh (S)

Department of Paediatrics and Child Health, University of Sana'a, Sana'a, Yemen.

Abdul Bari (A)

Independent newborn and child health consultant, Islamabad, Pakistan.

Sudha Basnet (S)

Center for Intervention Science in Maternal and Child Health, University of Bergen, Norway.
Department of Pediatrics, Tribhuvan University Institute of Medicine, Nepal.

Ashish Bavdekar (A)

King Edward Memorial (KEM) Hospital Pune, Department of Pediatrics, Pune, India.

Nita Bhandari (N)

Center for Health Research and Development, Society for Applied Studies, India.

Shinjini Bhatnagar (S)

Translational Health Science and Technology Institute, Faridabad, India.

Zulfiqar A Bhutta (ZA)

Institute for Global Health and Development, Aga Khan University, Pakistan.

Abdullah Brooks (A)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Mandeep Chadha (M)

Former Scientist, Indian Council of Medical Research (ICMR), National Institute of Virology, Pune, India.

Noel Chisaka (N)

World Bank, Washington DC, USA.

Monidarin Chou (M)

University of Health Sciences, Rodolphe Mérieux Laboratory, Phom Phen, Cambodia.
Ministry of Environment, Phom Phen, Cambodia.

Alexey W Clara (AW)

Centers for Disease Control, Central American Region, Guatemala City, Guatemala.

Tim Colbourn (T)

Institute for Global Health, University College London, London, United Kingdom.

Clare Cutland (C)

South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Valérie D'Acremont (V)

Swiss Tropical and Public Health Institute, Basel, Switzerland.

Marcela Echavarria (M)

Clinical Virology Unit, Centro de Educación Médica e Investigaciones Clínicas, Argentina.

Angela Gentile (A)

Department of Epidemiology, "R. Gutiérrez" Children's Hospital, Buenos Aires, Argentina.

Brad Gessner (B)

Pfizer Vaccines, Collegeville, Pennsylvania, USA.

Christopher J Gregory (CJ)

Division of Vector-borne Diseases, US Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Tabish Hazir (T)

Retired from Children Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan.

Patricia L Hibberd (PL)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Siddhivinayak Hirve (S)

King Edward Memorial (KEM) Hospital Research Center, Pune, India.

Shubhada Hooli (S)

Section of Pediatric Emergency Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

Imran Iqbal (I)

Department of Paediatrics, Combined Military Hospital Institute of Medical Sciences, Multan, Pakistan.

Prakash Jeena (P)

University of KwaZulu-Natal, Durban, South Africa.

Cissy B Kartasasmita (CB)

Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.

Carina King (C)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Institute for Global Health, University College London, London, United Kingdom.

Romina Libster (R)

Fundacion INFANT, Buenos Aires, Argentina.

Rakesh Lodha (R)

All India Institute of Medical Sciences, New Delhi, India.

Juan M Lozano (JM)

Florida International University, Miami, USA.

Marilla Lucero (M)

Research Institute for Tropical Medicine, Manila, Philippines.

Norman Lufesi (N)

Ministry of Health, Lilongwe, Malawi.

William B MacLeod (WB)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Shabir Ahmed Madhi (SA)

Faculty of Health Sciences, University of the Witwatersrand, Johannesburg.

Joseph L Mathew (JL)

Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Irene Maulen-Radovan (I)

Instituto Nactional de Pediatria Division de Investigacion Insurgentes, Mexico City, Mexico.

Eric D McCollum (ED)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Global Program in Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, USA.

Greta Mino (G)

Department of Infectious diseases, Guayaquil, Ecuador.

Charles Mwansambo (C)

Ministry of Health, Lilongwe, Malawi.

Mark I Neuman (MI)

Division of Emergency Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Ngoc Tuong Vy Nguyen (NTV)

Children Hospital No 1, Ho Chi Minh City, Vietnam.

Marta C Nunes (MC)

South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Pagbajabyn Nymadawa (P)

Mongolian Academy of Sciences, Academy of Medical Sciences, Ulaanbaatar, Mongolia.

Kerry-Ann F O'Grady (KF)

Australian Centre for Health Services Innovation, Queensland University of Technology, Kelvin Grove, Australia.

Jean-William Pape (JW)

GHESKIO Center, Port au Prince, Haiti.

Glaucia Paranhos-Baccala (G)

Fondation Merieux, Lyon, France.

Archana Patel (A)

Lata Medical Research Foundation, Nagpur and Datta Meghe Institute of Medical Sciences, Sawangi, India.

Valentina Sanchez Picot (VS)

Fondation Merieux, Lyon, France.

Mala Rakoto-Andrianarivelo (M)

Centre d'Infectiologie Charles Mérieux, Antananarivo, Madagascar.

Zeba Rasmussen (Z)

Division of International Epidemiology and Population Studies (DIEPS), Fogarty International Center (FIC), National Institute of Health (NIH), USA.

Vanessa Rouzier (V)

GHESKIO Center, Port au Prince, Haiti.

Graciela Russomando (G)

Universidad Nacional de Asuncion, Departamento de Biología Molecular y Genética, Instituto de Investigaciones en Ciencias de la Salud, Asuncion, Paraguay.

Raul O Ruvinsky (RO)

Dirección de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Buenos Aires, Argentina.

Salim Sadruddin (S)

Consultant/Retired World Health Organization (WHO) Staff, Geneva, Switzerland.

Samir K Saha (SK)

Child Health Research Foundation, Dhaka, Bangladesh.
Dhaka Shishu Hospital, Dhaka, Bangladesh.

Mathuram Santosham (M)

International Vaccine Access Center (IVAC), Department of International Health, Johns Hopkins University, Baltimore, Maryland, USA.

Sunit Singhi (S)

Medanta, The Medicity, Gurgaon, India.

Sajid Soofi (S)

Department of Pediatrics and Child Health, Aga Khan University, Pakistan.

Tor A Strand (TA)

Research Department, Innlandet Hospital Trust, Lillehammer, Norway.

Mariam Sylla (M)

Gabriel Touré Hospital, Department of Pediatrics, Bamako, Mali.

Somsak Thamthitiwat (S)

Division of Global Health Protection, Thailand Ministry of Public Health - US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.

Donald M Thea (DM)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Claudia Turner (C)

Shoklo Malaria Research Unit, Mae Sot, Thailand.

Philippe Vanhems (P)

Unité d'Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France.
Centre International de Recherche en Infectiologie, École Nationale Supérieure de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Nitya Wadhwa (N)

Translational Health Science and Technology Institute, Faridabad, India.

Jianwei Wang (J)

Chinese Academy of Medical Sciences & Peking Union, Medical College Institute of Pathogen Biology, MOH Key Laboratory of Systems Biology of Pathogens and Dr Christophe Mérieux Laboratory, Beijing, China.

Syed Ma Zaman (SM)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Harry Campbell (H)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.

Harish Nair (H)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom.

Shamim Ahmad Qazi (SA)

Consultant/Retired World Health Organization (WHO) Staff, Geneva, Switzerland.

Yasir Bin Nisar (YB)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization (WHO), Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH